HomepageSSKN • OTCMKTS
add
STRATA Skin Sciences Inc
Vorige slotkoers
$Â 0,22
Dag-range
$Â 0,18 - $Â 0,23
Jaar-range
$Â 0,12 - $Â 3,86
Beurswaarde
1,12Â mln. USD
Gem. volume
85,49K
Koers/winst
-
Dividendrendement
-
Primaire beurs
OTCMKTS
Marktnieuws
.INX
0,11%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 9,29Â mln. | -2,97% |
Bedrijfskosten | 5,58Â mln. | -3,51% |
Netto inkomsten | 58,00K | 101,27% |
Netto winstmarge | 0,62 | 101,30% |
Winst per aandeel | — | — |
EBITDA | 858,00K | -29,27% |
Effectief belastingtarief | 17,14% | — |
Balans
Totale activa
Totale passiva
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 7,91Â mln. | 8,97% |
Totale activa | 30,52Â mln. | -12,62% |
Totale passiva | 27,61Â mln. | -7,82% |
Totaal aandelenvermogen | 2,91 mln. | — |
Uitstaande aandelen | 5,89 mln. | — |
Koers-boekwaardeverhouding | 0,45 | — |
Rendement op activa | 0,30% | — |
Rendement op kapitaal | 0,50% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 58,00K | 101,27% |
Operationele kasstroom | -239,00K | -134,00% |
Kasstroom uit beleggingen | -312,00K | 38,10% |
Kasstroom uit financiering | 1,39 mln. | — |
Nettomutatie in liquide middelen | 836,00K | 320,10% |
Vrije kasstroom | -1,70Â mln. | -220,18% |
Over
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
The company's flagship product, XTRAC, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind in the European Union.
In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County. Wikipedia
Opgericht
1 jan 1989
Hoofdvestiging
Website
Werknemers
114